Pentapeptide-18 vs Pal-GHK: picking a topical for your goal

Pentapeptide-18 and Pal-GHK show up in the same skincare aisle conversation constantly, usually because someone read a serum label and wants to know which ingredient is actually doing the work. Short answer: Pentapeptide-18 targets the muscle-contraction side of wrinkle formation, Pal-GHK targets collagen production, and for most people chasing fine lines, they're addressing different parts of the same problem.

I get this question a lot from clients who've been sold a serum with six peptides on the ingredient list and no explanation of what any of them do. So let's separate the two.

What each one is actually built to do

Pentapeptide-18, sold under the name Leuphasyl, mimics a natural signaling molecule called enkephalin. It binds opioid receptors on the nerve endings that trigger facial muscle contraction, reducing the calcium influx that causes the muscle to fire. That means less contraction and less expression-line deepening over time. It's grouped with Argireline and Syn-Ake in what the industry calls the "topical Botox" family, though the comparison to actual Botox is a stretch. Injection blocks a nerve signal directly. A topical cream diffusing through skin layers is working with a fraction of that potency.

Pal-GHK is a different animal entirely. It's palmitoylated GHK, meaning a fatty acid tail has been attached to the parent GHK molecule so it penetrates skin more efficiently. Once it's in, it activates fibroblasts through the TGF-beta pathway, which is the signal that tells your skin cells to start producing collagen, elastin, and glycosaminoglycans. This is not a relaxer. It's a builder. Pal-GHK is one of the two peptides in Matrixyl 3000, one of the most widely used anti-aging ingredients in commercial skincare, paired there with a peptide called Rigin.

So the practical split: Pentapeptide-18 slows down the mechanical cause of expression lines, Pal-GHK works on rebuilding the structural material underneath the skin. If your main concern is crow's feet from squinting and smiling, Pentapeptide-18 addresses that mechanism more directly. If your concern is general skin thinning, loss of firmness, or slower healing, Pal-GHK is doing the more relevant job.

Weighing the evidence

Both of these sit in what the field calls "emerging" territory. Pentapeptide-18's strongest data point is a human cohort study that reported reduced sebum and improved facial wrinkles, but the peptide was tested inside a retinol co-formulation, not on its own. That's a real limitation. You can't tell how much of the improvement came from the retinol and how much from the peptide. The rest of its published support, including a structural characterization study and an earlier mechanistic paper, is in-vitro or computational work, useful for understanding mechanism but not proof of what happens on your face.

Pal-GHK's human-relevant citation is a 2025 review on topical anti-wrinkle peptides rather than a fresh randomized trial. That's still worth something. Reviews synthesize a body of smaller studies and Pal-GHK's parent compound GHK-Cu has one of the longer published track records in dermal peptide research, so Pal-GHK inherits a reasonable mechanistic case even without a dedicated large trial of its own.

Nobody has run a head-to-head human trial pitting these two against each other. If you're looking for a study that settles this comparison directly, it doesn't exist yet. What you have instead is two peptides with plausible, distinct mechanisms and thin but real human-adjacent data on each.

Cost, side effects, and who each one actually suits

Both are topical-only, both carry a benign safety profile, and neither has documented adverse effects specific to the isolated peptide in the source data. That's the easy part of this comparison. Where they diverge is in what they're formulated for and how you'll typically encounter them.

Pentapeptide-18 usually shows up in serums already stacked with Argireline or SNAP-8, aimed at people specifically bothered by dynamic wrinkles, the kind that come from repeated facial movement. If you're 30 to 45 and starting to notice lines forming around expression points, this is the more targeted pick.

Pal-GHK shows up baked into broader anti-aging formulations, most commonly as part of Matrixyl 3000, aimed at general collagen support and skin resilience. If your concern is more about overall skin quality, texture, and firmness rather than one specific line pattern, this is the better fit. It also has the deeper mechanistic pedigree given how much research exists on its parent molecule GHK-Cu.

Neither peptide has a standardized dosing protocol the way injectable peptides do since these are formulated into topical products at manufacturer-set concentrations, and no standalone concentration figure has been published for either one in isolation. Now the part my lawyer makes me say, and he's right: the doses and schedules here are for educational and informational purposes only. These peptides are sold for research use only and are not FDA-approved drugs. This is not medical advice. Consult a qualified physician before beginning any protocol.

The real answer for most people

If you're choosing one, match it to your actual concern rather than picking whichever has the flashier marketing copy. Pentapeptide-18 for expression-line softening, Pal-GHK for collagen and structural support. If you can't decide, most commercial serums already combine peptides from both categories, which is why you rarely see them marketed as an either-or choice in the first place. I've had clients run both in a layered routine without any conflict, since they're not competing for the same receptor or pathway.

What I'd actually watch for is whether the product you're buying discloses a real concentration and comes from a manufacturer running third-party testing. A peptide with decent mechanistic support in a poorly formulated, under-dosed serum will underperform a lesser-studied peptide in a well-made one. That's a bigger variable than the Pentapeptide-18 versus Pal-GHK question most people are actually asking.

For more on how these fit into a broader topical routine, see the comparison on Syn-Ake and Pentapeptide-18 and the breakdown of Matrixyl versus Decapeptide-12 for a sense of where these compounds sit relative to the rest of the cosmetic peptide field.